Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-29 @ 6:36 PM
Study NCT ID:
NCT01535261
Status:
COMPLETED
Last Update Posted:
2016-10-27
First Post:
2012-02-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2015-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-14
First Submit QC Date:
None
Study First Post Date:
2012-02-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-16
Results First Submit QC Date:
None
Results First Post Date:
2016-06-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-21
Last Update Post Date:
2016-10-27
Last Update Post Date Type:
ESTIMATED